Yıl: 2022 Cilt: 31 Sayı: 3 Sayfa Aralığı: 234 - 236 Metin Dili: İngilizce DOI: 10.4274/mirt.galenos.2021.68926 İndeks Tarihi: 03-11-2022

Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment

Öz:
Nasolacrimal duct obstruction (NLDO) is a rare complication after radioiodine therapy and may cause false positive 131I uptake at the point of obstruction in 131I whole body scan. Here, we report a 59-year-old female patient with papillary thyroid cancer treated with total thyroidectomy followed by 131I therapy. 131I whole body scan revealed focal uptake in the head. Single photon emission computed tomography/computed tomography (CT) showed focal uptake at the right proximal nasolacrimal duct. The ophthalmologic examination and the diagnostic maxillofacial CT confirmed the diagnosis of NLDO.
Anahtar Kelime:

131I SPECT/BT’de Nazolakrimal Kanal Tıkanıklığı: Tek-doz RAİ Tedavisinin Bir Komplikasyonu Olarak Atipik Yanlış Pozitif Paranazal Radyoiyot Tutulumu

Öz:
Nazolakrimal kanal tıkanıklığı (NLKT), radyoiyot tedavisi sonrası nadir görülen bir komplikasyondur ve 131I tüm vücut tarama sintigrafisinde tıkanma noktasında yanlış pozitif 131I tutulumuna neden olabilir. Burada, 59 yaşında papiller tiroid kanserli, total tiroidektomi ve ardından 131I tedavisi uygulanan bir kadın hasta sunuldu. 131I tüm vücut tarama sintigrafisinde kafada odaksal bir 131I tutulumu izlendi. Tek foton emisyon tomografisi/ bilgisayarlı tomografi (BT) sağ nazolakrimal kanal proksimal kesiminde fokal 131I tutulumu gösterdi. Oftalmolojik muayene ve tanısal maksillofasiyal BT, NLKT tanısını doğruladı.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • Ali MJ. Iodine-131 Therapy and nasolacrimal duct obstructions: what we know and what we need to know. Ophthalmic Plast Reconstr Surg 2016;32:243-248.
  • Burns JA, Morgenstern KE, Cahill KV, Foster JA, Jhiang SM, Kloos RT. Nasolacrimal obstruction secondary to I(131) therapy. Ophthalmic Plast Reconstr Surg 2004;20:126-129.
  • Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A. The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma. Clin Nucl Med 2007;32:696-699.
  • Morgenstern KE, Vadysirisack DD, Zhang Z, Cahill KV, Foster JA, Burns JA, Kloos RT, Jhiang SM. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients. Ophthalmic Plast Reconstr Surg 2005;21:337-344.
  • Yuoness S, Rachinsky I, Driedger AA, Belhocine TZ. Differentiated thyroid cancer with epiphora: detection of nasolacrimal duct obstruction on I-131 SPECT/CT. Clin Nucl Med 2011;36:1149-1152.
  • Fard-Esfahani A, Farzanefar S, Fallahi B, Beiki D, Saghari M, EmamiArdekani A, Majdi M, Eftekhari M. Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer. Nucl Med Commun 2012;33:1077-1080.
  • Brockmann H, Wilhelm K, Joe A, Palmedo H, Biersack HJ. Nasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature. Clin Nucl Med 2005;30:543-545.
  • Ali MJ, Vyakaranam AR, Rao JE, Prasad G, Reddy PV. Iodine-131 therapy and lacrimal drainage system toxicity: nasal localization studies using whole body nuclear scintigraphy and SPECT-CT. Ophthalmic Plast Reconstr Surg 2017;33:13-16.
APA Filizoglu N, Öksüzoğlu K, Özgüven S, erdil t, Buğdaycı O (2022). Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. , 234 - 236. 10.4274/mirt.galenos.2021.68926
Chicago Filizoglu Nuh,Öksüzoğlu Kevser,Özgüven Salih,erdil tanju yusuf,Buğdaycı Onur Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. (2022): 234 - 236. 10.4274/mirt.galenos.2021.68926
MLA Filizoglu Nuh,Öksüzoğlu Kevser,Özgüven Salih,erdil tanju yusuf,Buğdaycı Onur Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. , 2022, ss.234 - 236. 10.4274/mirt.galenos.2021.68926
AMA Filizoglu N,Öksüzoğlu K,Özgüven S,erdil t,Buğdaycı O Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. . 2022; 234 - 236. 10.4274/mirt.galenos.2021.68926
Vancouver Filizoglu N,Öksüzoğlu K,Özgüven S,erdil t,Buğdaycı O Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. . 2022; 234 - 236. 10.4274/mirt.galenos.2021.68926
IEEE Filizoglu N,Öksüzoğlu K,Özgüven S,erdil t,Buğdaycı O "Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment." , ss.234 - 236, 2022. 10.4274/mirt.galenos.2021.68926
ISNAD Filizoglu, Nuh vd. "Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment". (2022), 234-236. https://doi.org/10.4274/mirt.galenos.2021.68926
APA Filizoglu N, Öksüzoğlu K, Özgüven S, erdil t, Buğdaycı O (2022). Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. Molecular Imaging and Radionuclide Therapy, 31(3), 234 - 236. 10.4274/mirt.galenos.2021.68926
Chicago Filizoglu Nuh,Öksüzoğlu Kevser,Özgüven Salih,erdil tanju yusuf,Buğdaycı Onur Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. Molecular Imaging and Radionuclide Therapy 31, no.3 (2022): 234 - 236. 10.4274/mirt.galenos.2021.68926
MLA Filizoglu Nuh,Öksüzoğlu Kevser,Özgüven Salih,erdil tanju yusuf,Buğdaycı Onur Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. Molecular Imaging and Radionuclide Therapy, vol.31, no.3, 2022, ss.234 - 236. 10.4274/mirt.galenos.2021.68926
AMA Filizoglu N,Öksüzoğlu K,Özgüven S,erdil t,Buğdaycı O Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. Molecular Imaging and Radionuclide Therapy. 2022; 31(3): 234 - 236. 10.4274/mirt.galenos.2021.68926
Vancouver Filizoglu N,Öksüzoğlu K,Özgüven S,erdil t,Buğdaycı O Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment. Molecular Imaging and Radionuclide Therapy. 2022; 31(3): 234 - 236. 10.4274/mirt.galenos.2021.68926
IEEE Filizoglu N,Öksüzoğlu K,Özgüven S,erdil t,Buğdaycı O "Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment." Molecular Imaging and Radionuclide Therapy, 31, ss.234 - 236, 2022. 10.4274/mirt.galenos.2021.68926
ISNAD Filizoglu, Nuh vd. "Nasolacrimal Duct Obstruction on 131I SPECT/CT: Atypical False positive Paranasal Radioiodine Uptake as a Complication of Singledose RAI Treatment". Molecular Imaging and Radionuclide Therapy 31/3 (2022), 234-236. https://doi.org/10.4274/mirt.galenos.2021.68926